According to a recent LinkedIn post from Cornerstone Robotics, the company recently exhibited its Sentire® Surgical System at the EAU26 Annual Congress in London, organized by the European Association of Urology. The post notes that this was the company’s first appearance at the event and that more than 100 surgeons attended in-booth demonstrations and provided positive feedback.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The company’s LinkedIn post also indicates that this activity aligns with a broader U.K. strategy, referencing a local business centre and an ongoing clinical evaluation program with Portsmouth Hospitals University NHS Trust. For investors, these developments may signal progress in clinical validation, market awareness, and potential future commercialization opportunities in European robotic surgery, particularly within urology.

